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Abstract
Emerging evidence indicates that gene products implicated in human cancers often cluster together in ‘‘hot spots’’ in
protein-protein interaction (PPI) networks. Additionally, small sub-networks within PPI networks that demonstrate
synergistic differential expression with respect to tumorigenic phenotypes were recently shown to be more accurate
classifiers of disease progression when compared to single targets identified by traditional approaches. However, many of
these studies rely exclusively on mRNA expression data, a useful but limited measure of cellular activity. Proteomic profiling
experiments provide information at the post-translational level, yet they generally screen only a limited fraction of the
proteome. Here, we demonstrate that integration of these complementary data sources with a ‘‘proteomics-first’’ approach
can enhance the discovery of candidate sub-networks in cancer that are well-suited for mechanistic validation in disease.
We propose that small changes in the mRNA expression of multiple genes in the neighborhood of a protein-hub can be
synergistically associated with significant changes in the activity of that protein and its network neighbors. Further, we
hypothesize that proteomic targets with significant fold change between phenotype and control may be used to ‘‘seed’’ a
search for small PPI sub-networks that are functionally associated with these targets. To test this hypothesis, we select
proteomic targets having significant expression changes in human colorectal cancer (CRC) from two independent 2-D gel-
based screens. Then, we use random walk based models of network crosstalk and develop novel reference models to
identify sub-networks that are statistically significant in terms of their functional association with these proteomic targets.
Subsequently, using an information-theoretic measure, we evaluate synergistic changes in the activity of identified sub-
networks based on genome-wide screens of mRNA expression in CRC. Cross-classification experiments to predict disease
class show excellent performance using only a few sub-networks, underwriting the strength of the proposed approach in
discovering relevant and reproducible sub-networks.
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Introduction
Colorectal cancer (CRC) is the second leading cause of cancer
death in adult Americans [1]. Interest in this complex disease is
represented by a very mature body of research, much of it at the
genomic level. Yet the identification and verification of proteins
that have a functional role in the patho-physiology of CRC
remains an important goal as proteins directly mediate the
functions dysregulated in the disease. Modern, high-throughput
proteomic methods provide one way of profiling the significant
changes in protein expression of tumor samples with respect to
control, using tissue biopsies obtained from patients diagnosed
with this disease [2–5].
Proteomic screening techniques are particularly useful for
furthering the understanding of the mechanisms that underlie
complex phenotypes like CRC, in that they provide information at
the post-translational level. However, due to various biological and
experimental constraints (e.g., ascertainment bias and physical
properties of proteins), proteomic methods may screen only a
limited fraction of proteins and protein isoforms present in cells
and tissues. We propose that this limitation may be mitigated
through the integration of proteomic data with genome scale data
sources, such as measurements of gene expression. In addition,
protein-protein interaction (PPI) databases, which are rapidly
growing in terms of both the quality and quantity of their
annotations, provide another source of genome scale data
integration [6]. Such integrative approaches can potentially lead
to functional inference at the systems level, through identification
of pathways and molecular sub-networks that are implicated in
CRC.
In support of this approach, a recent review by Ideker and
Sharan [7] summarizes studies that indicate that genes with a role
in cancer tend to cluster together on well-connected sub-networks
of protein-protein interactions. This suggests a hypothesis that
the synergistic expression of multiple cancer-related genes at
the level of mRNA can co-regulate the expression of proteins in
their immediate ‘‘network neighborhood’’. These differentially
expressed proteins may be captured by expression proteomics
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ideal starting place to search for sub-networks with a possible role
in the disease.
The effectiveness of network-based approaches to the identifi-
cation of multiple disease markers has been demonstrated in the
context of various diseases, including Huntington’s disease [8], the
inflammatory response [9], and human breast cancer [10].
Furthermore, it was recently shown that ‘‘differentially expressed
sub-network markers’’ were more accurate predictors of metastasis
in breast cancer (compared to single gene markers) [11]. However,
existing approaches are generally limited to mRNA expression
data in terms of quantification of molecular expression, which
captures post-transcriptional activity only to a limited extent
[12,13]. Consequently, inclusion of protein expression data in the
search for sub-network markers has the potential to improve the
effectiveness of systems biology approaches [14]. However, it
remains largely unknown how a network-based approach may be
enhanced when starting with proteomic data.
In this paper, we propose a novel computational approach that
takes into account certain topological features of the interactome,
namely connectivity and proximity, for searching the neighbor-
hoods of proteomic targets to find significant sub-networks
implicated in CRC. In doing so, we partly overcome (i) the bias
inherent in proteomic profiling experiments, particularly those
that are gel-based, which are typically limited to capturing changes
only in relatively abundant proteins and (ii) the noise, missing data,
and ascertainment bias in PPI data. This is accomplished by
assessing the functional association between proteins based on the
quantification of the statistical significance of network crosstalk
through information-flow based modeling of the PPI network and
development of a reference model that takes into account the
network connectivity of proteomic targets. We hypothesize that
identification of candidate sub-networks with a significant
association to proteomic targets can reveal proteins that are not
detected to be differentially expressed at the level of the proteome,
but whose activity in the network may play a key role in
maintaining the phenotype. Consequently, the proposed frame-
work provides a means for expanding proteome expression data to
infer a role for proteins that exhibit significant crosstalk to the
proteomic targets. The flow of the proposed computational
framework is illustrated in Figure 1.
A key objective of this study is to systematically elaborate a
proteomics-driven approach as a sound method for inferring small
sub-networks implicated in complex phenotypes, and ultimately
make these methods practically available to a wider community of
researchers working in this area. For this purpose, we ground our
approach on the hypothesis that the observed fold change of
the proteomic targets may be associated with the synergistic
dysregulation of their interacting partners at the level of mRNA.
From a computational perspective, our hypothesis is based on the
premise that sub-networks which exhibit significant association
with the proteomic targets should also show a significant change in
activity between control and cancer. To test this hypothesis, we
first score each protein in the network based on their crosstalk with
the proteomic targets. In order to account for noise, incomplete-
ness of data, and ascertainment bias, we also develop novel
methods for assessing the significance of these ‘‘crosstalk scores’’.
Then, for each proteomic target, we identify a candidate sub-
network that is composed of its interacting partners with significant
crosstalk scores. Subsequently, using an information theoretic
measure, we evaluate the synergistic differential expression of these
candidate sub-networks between control and disease, based on
changes in mRNA expression obtained from microarray experi-
ments performed on tissue biopsies collected from a cohort of
patients with CRC. Finally, using the sub-networks that exhibit
significant synergistic dysregulation as features, we develop
classifiers to predict disease class across different data sets.
The proposed computational approach for assessing functional
association between proteomic targets and other proteins uses a
random-walk based algorithm. Recently, Kohler et al. [15] and
Chen et al. [16] used similar network algorithms to prioritize
candidate disease genes implicated by linkage analysis in a variety
of human diseases. Vanunu and Sharan [17] developed a global,
propagation-based method that exploits information on known
causal disease genes and PPI confidence scores. Their method
more accurately recovered known disease gene relationships
compared to several other extant methods. In contrast to these
applications and rather than using raw scores obtained by such
information flow based algorithms, we develop reference models to
assess the statistical significance of these scores, with a view to
identifying proteins that are significantly associated with proteomic
targets. Furthermore, our biological hypothesis, which drives our
approach, is that targets (proteomic or genomic) significant for the
CRC phenotype may reside in or near cancer hotspots in the
network, and thus present an ideal starting place to search for
high-value sub-networks associated with the disease. Therefore,
our computational approach does not rely on canonical disease-
related genes or proteins; rather, it is a global, unbiased search that
tries to identify network interactions statistically significant with
respect to all targets in an experimentally-derived set.
Our previous work in this area [5] was limited in scope due to
the lack of access to the topology of the commercial PPI we
employed. This prevented us from assessing the importance of
topology for sub-network generation, which is the primary focus of
our computational approach in this study. Likewise, our network
scoring and statistical hypothesis testing were all greatly limited in
the previous work due to incomplete access to an unpublished
microarray data. For the same reason we were practically
prevented from iteratively adjusting network search parameters
Author Summary
Intensive research on cancer has led to an understanding
of many individual genes that may be important for the
initiation and progression of tumors. However, since
cancer is a progressive disease that results from accumu-
lation of multiple mutations likely acting in concert,
individual markers can only provide limited insights into
cellular mechanisms that underlie tumorigenesis. For this
reason, recent studies focus on identification of ‘‘sub-
network markers’’, that is, functionally associated genes
that exhibit coordinate changes in molecular expression
during cancer progression. However, expression of genes
is most frequently interrogated at the mRNA level, which
captures functional activity of genes only to a limited
extent. Screening of protein expression, on the other hand,
provides information on the abundance of functional gene
products, but its scale is often limited compared to
screening of mRNA expression. In this article, we develop a
proteomics-driven computational method that searches
for sub-network markers in human colorectal cancer,
based on a seed of differentially expressed proteins
identified by proteomic screening. Our results show that
significant changes in the expression of these proteins is
likely to be associated with coordinate changes in the
expression of the genes whose products are functionally
associated with these proteins. This analysis leads to novel
insights in the synergistic processes that underlie tumor-
igenesis.
Functional Sub-Networks in Human Colorectal Cancer
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of candidate sub-networks for scoring.
Here we describe a new network search method for finding
high-value candidate sub-networks associated with CRC. To
overcome the limitations of the previous study and to permit
independent evaluation of our methods, we utilize a public PPI
(HPRD) and public microarrays (Gene Expression Omnibus) to
evaluate performance using two independent sets of proteomic
targets obtained by 2D-PAGE that are also publically available.
We compare this result to that obtained using a set of CRC driver
gene mutants as seeds for the network search. The basis for this
test is the hypothesis that if mutated gene products map to cancer
hotspots on the network, they would be similarly useful as seeds for
our network search algorithm. To reveal the practical utility of our
integrative approach, and to extend it beyond merely a theoretical
computational framework, we validate by western blot several
targets in a sub-network predicted by our method to be
dysregulated, using a cohort of tissue biopsies not used in the
original proteomic screen. Finally, we employ a cross-validation
approach to compare the disease classification performance of the
proteomic-versus genomic-derived sub-networks.
Our results show that the proposed proteomics-driven ap-
proach, as it integrates a variety of biologically relevant data, can
identify significant sub-networks implicated in a complex pheno-
type, i.e. CRC. The definition of terminology frequently used in
this paper is provided in Table 1.
Results
We searched the PPI network obtained from the Human
Protein Reference Database (HPRD) for CRC-implicated sub-
networks using two distinct sets of proteomic targets from Nibbe et
al. [5] (n=67) and Friedman et al. [2] (n=55). Both sets contain
significant targets of CRC obtained by a proteomic screen using
tissue biopsies (tumor and matched controls) obtained from twelve
and six patients, respectively (see Proteomic Methods for details of
the screen performed in our lab). We call these targets proteomic
seeds. The HPRD PPI network was downloaded from the HPRD
website on September 2008 and contained 35023 binary inter-
actions between 9299 proteins, as well as 1060 protein complexes
consisting of 2146 proteins. We integrated the binary interactions
and protein complexes using a matrix model (e.g., each complex is
represented as a clique between the proteins in the complex), to
obtain a PPI network composed of 42781 binary interactions
among 9442 proteins. 60 of the proteomic seeds from the data of
Nibbe et al. had at least one interaction in HPRD, while 37 of the
Figure 1. Schematic of an integrated, proteomics-first approach for the discovery of functional, candidate sub-networks in a
disease phenotype. Disease targets significant for a phenotype (e.g. cancer) are used to seed an information-flow based search of the human
interactome for candidate sub-networks subsequently classified as crosstalkers or interactors. Candidate sub-networks are then scored between test
and control (e.g. normal vs. tumor) using the mutual information of aggregate mRNA expression data as a proxy for synergistic dysregulation. High-
scoring sub-networks may be experimentally validated for their role in disease.
doi:10.1371/journal.pcbi.1000639.g001
Functional Sub-Networks in Human Colorectal Cancer
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in HPRD. 14 of the proteins in the two seed sets were common.
For every protein in HPRD, our procedure assigns a score
based on the protein’s proximity and connectivity to all the seeds
(see Materials and Methods). If the score is not significant
(p,0.001) but the protein directly interacts with one or more of
the seeds, we call it an interactor, whereas a crosstalker is any protein
whose score is significant. Note that a crosstalker is generally (but
not necessarily always) an interactor since a significant crosstalk
score for a protein indicates that it is in the network neighborhood
of one or more of the seeds, however, there are many interactors
that do not qualify as crosstalkers. Overall, this procedure revealed
233 crosstalkers for Nibbe seeds, and 210 crosstalkers for Fried-
man seeds.
Subsequently, for each proteomic seed in each set, a candidate
sub-network consisting of its interactors, termed the interactor
sub-network, was obtained, resulting in a total of 55 interactor sub-
networks (46 for Nibbe seeds exclusively, 23 for Friedman seeds
exclusively, and 14 additional sub-networks for both). Similarly,
for each seed in both sets, a crosstalker sub-network was obtained.
Thus, for every seed there are two corresponding sub-networks, an
interactor sub-network and a crosstalker sub-network. The
proteins in an interactor sub-network are merely characterized
by their direct interactions with the corresponding proteomic seed.
By contrast, proteins in a crosstalker sub-network are character-
ized by their degree of functional association with all proteomic
seeds.
Relationship of Expression between Crosstalkers and
Individual Proteins in HPRD at the Level of mRNA
We evaluated the individual differential gene expression of each
crosstalker identified using the Nibbe and Friedman proteomic
seeds using two microarray datasets obtained from GEO
(GSE10950 & GSE8671). GSE8671 represents 64 experiments
using mRNA isolated from tissue biopsies obtained from 32
patients (matched tumor and adjacent normal mucosa) performed
on an Affymetrix GeneChip (Human U133 Plus 2.0). Similarly,
GSE10950 represents 48 experiments on matched tissue biopsies
(24 patients) performed on an Illumina array (Human ref-8, v2.0).
The cumulative distribution of individual differential expression
scores for proteomic seeds, (and a seed of CRC driver genes
discussed later), as well as all proteins in the network computed as
describedintheMaterialsandMethodssection,isshowninFigure2
Table 1. Definition of terminology used frequently in this paper.
Term Definition
Proteomic seed A protein that is significantly differentially expressed between tumor and control, as identified by
proteomic screening.
Proteomic seed set A set of proteomic seeds that are identified together in one proteomic screening cohort.
Network crosstalk The degree of network proximity and connectivity between (groups) of proteins, modeled as the
amount of ‘‘information flow’’ between these proteins in a PPI network.
Crosstalker A protein that exhibits statistically significant network crosstalk with proteins in a particular
proteomic seed set.
Interactor sub-network A sub-network of the PPI network induced by the interacting partners of a particular proteomic seed.
Crosstalker sub-network A sub-network of the PPI network induced by the interacting partners of a particular proteomic seed,
which are also identified as crosstalkers with respect to the corresponding proteomic seed set.
Synergy or Synergistic dysregulation Coordinate mRNA-level differential expression of a group of genes in the phenotype.
doi:10.1371/journal.pcbi.1000639.t001
Figure 2. Crosstalkers are not significant at level of individual
mRNA expression. Cumulative distribution of differential expression
for crosstalkers identified using two proteomic seeds (Nibbe et al.,
Friedman et al.), a seed of CRC driver genes (Sjo ¨blom et al.), and all
proteins in the HPRD PPI network, as quantified by mutual information
with phenotype, using GSE8671 and GSE10950.
doi:10.1371/journal.pcbi.1000639.g002
Functional Sub-Networks in Human Colorectal Cancer
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differential expression is quantified). As seen in the figure, we found
no significant difference in the distribution of individual differential
expression of the crosstalkers, as compared to the distribution of
differential expression of all proteins in the HPRD network. This
observation indicates that at the level of individual genes, significant
network crosstalk with proteomic seeds in CRC is not associated
with transcriptomic dysregulation in CRC.
Synergistic Regulation of Sub-Networks Induced by
Proteomic Seeds
Forthepurposeofdiscussion wewillrefertoa sub-networkbythe
proteomic seed that induced the sub-network (e.g. TCP1). For each
version of each sub-network we computed the mutual information
(MI) of each sub-network between control and tumor using the
mRNA expression data from microarrays GSE10950 and
GSE8671 (see Computational Methods), and we used this score to
estimate the significance of the various networks in differentiating
the phenotype (Figure 1). The comparison of mutual information
for the two versions of each sub-network associated with the Nibbe
seed is shown in Figure 3. We plotted the results only for those
(crosstalker) sub-networks where the mutual information exceeded
0.35 (approximately 1s from random mean). The purpose of this
analysis is to understand how the synergy of each crosstalker sub-
network compares to that of its corresponding interactor sub-
network. The MI and significance scores for all sub-networks can be
found in Supplemental Table S1.
Of the 46 candidate sub-networks associated with Nibbe
proteomic seeds, 10 unique interactor sub-networks (green
squares) exhibited significant MI scores. For five of these sub-
networks (CCT2, TCP1, SYNCRIP, HNRPF and HNRPH1) the
crosstalker version of the sub-networks was found to have
enhanced MI on one or the other microarray datasets. Two
crosstalker sub-networks (red diamonds), CCT2 and TCP1, show
improvement over their corresponding interactor sub-network on
both arrays. Notably, on GSE10950, the mutual information score
of the TPI1 crosstalker sub-network is significant, while the
corresponding interactor sub-network failed to show significance.
Figure 4 shows the corresponding plots for the Friedman
proteomic seeds. Here, seven unique interactor sub-networks have
significant MI scores; two of them (ANXA3 and PSMA6) were
common to both sets of microarray data. For the Friedman seeds,
the crosstalkers for candidate sub-network TUBA1B showed
dramatically increased mutual information compared to its
interactor network. Furthermore, four other crosstalker sub-
networks (associated with MYL9, GARS, ANXA3 and GSTP1) all
revealed much higher synergy compared to their corresponding
interactor sub-networks, two of which (MYL9, GSTP1) failed to
show significance on either array. We discuss a possible
explanation for these findings in the Discussion section.
Figures 5a and 5b show unions of crosstalker sub-networks
associated with the Friedman and Nibbe seeds, respectively, for
which the synergy was higher than the corresponding interactor
sub-network. The graphs reveal that many proteomic seeds reside
within or near dense sub-networks of crosstalkers.
Post-Trancriptional Dysregulation of TCP1 Sub-Network
We observed that several of the sub-networks generated using
the two proteomic seed sets contained proteins in common. In
particular, certain sub-units of the TCP1 complex exhibited
marked crosstalk in the sub-network induced by CCT2 in the
Nibbe seed, and TUBA1B in the Friedman seed (Figure 4). In
addition, we had previously shown [5] that certain sub-units of this
complex (CCT3, CCT5, and CCT7) were also significant for the
late-stage CRC phenotype, as revealed by a similar network
scoring methodology but using a commercial PPI unrelated to
HPRD.
TCP1 (or TCPa) is a hetero-oligomeric complex comprised of
two stacked ring structures, each composed of eight known
subunits and plays a functional role in maintaining the CRC
phenotype. Specifically, it was shown [18] to be required for the
proper biogenesis of PLK1, a kinase that has a critical role in
cytokinesis. However, other than their role as sub-units in the
formation of the TCP complex little is known about the
independent role, if any, of these sub-units in CRC [19].
Consequently, these targets present an opportunity for follow-on
mechanistic studies. For this reason, we verified the protein
expression of TCP1, CCT3, CCT5, CCT7, and PLK1 by western
blot in a separate cohort of three patient sample pairs not used in
screening phase, and compared this to the average expression at
the level of mRNA (Figure 6). Consistent with our hypothesis, the
data indicate co-regulation at the level of mRNA and protein, but
also reveal the wide variability of expression of these targets among
individual patients. CCT3 and CCT7 were dramatically over-
expressed in two patients (507 and 534), but less so in patient 540,
which was similar to the pattern for PLK1.
Synergistic Dysregulation of Sub-Networks Induced by
CRC Driver-Gene Seeds
Although these data show that proteomic seeds are well-suited
for identifying synergistically dysregulated sub-networks, we
wished to investigate the power of genetically identified seed sets
in discovering significant sub-networks. As CRC is commonly
thought to be caused by the accumulation of somatic mutations, a
number of cancer research labs have collaborated to conduct
whole genome sequencing to identify the genes thought to be
‘‘drivers’’ in cancer, i.e. those represented by the set of genes that
appeared most frequently mutated in a robust cohort of clinical
biopsies. The results of one such study on human breast and colon
cancer were recently reported by Sjo ¨blom et al. [20]. We
hypothesized that the gene products of the CRC driver genes
reported in this study would be located at hotspots in the
interactome. Further, if the mutations lead to dysregulation of
neighboring genes at the level of mRNA, then the seed should
reveal significant sub-networks using our method. Additionally,
since there is less bias in PCR sequencing and high genome
coverage, at least as compared to proteomic profiling, we supposed
that driver gene seeds (n=42) might be superior both in terms of
the number and significance of the sub-networks identified.
As shown in Figure 7, when scored by GSE8671, only four
significant sub-networks were found. Strikingly, for every one of
them, only the crosstalker sub-networks were significant. Using
GSE10950, seven sub-networks of crosstalkers were significant,
including all four found on GSE8671. For all but two of the sub-
networks(P2RX7, OBSCN), the crosstalkers show substantially higher
synergistic differential expression as compared to their interactor
counterparts. Notably, APC, a tumor suppressor gene widely viewed
as the ‘‘gate-keeper’’ in CRC, was associated with a significantly
dysregulated sub-network with respect to both arrays, and of all the
genes in the driver seed it was found to be mutated in the highest
percentage (90%) of the clinical samples. This expected finding may
be viewed as a positive control for our analytical method.
In terms of the overall number of significant sub-networks
identified, however, there was no apparent improvement using the
driver gene seed set versus either proteomic seed set. Additionally,
a number of the significant crosstalk sub-networks identified by the
proteomic seeds show markedly higher synergy (MI.0.60) than all
but one (EVL) of the sub-networks found by the driver gene seed.
Functional Sub-Networks in Human Colorectal Cancer
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We evaluated the quality of the crosstalker versus interactor sub-
networks in terms of their ability to classify tumor versus control on
the microarrays, using an SVM-based classifier in a cross-validation
approach (see Materials and Methods). The significant sub-networks
in each group were first ranked by MI, and the features were valued
bysuperposingthe mRNAexpression values of eachgeneinthe sub-
network. When trained on GSE10950 and validated on GSE8671,
proteomic crosstalkers outperformed the interactor sub-networks
(both proteomic and genomic) when the number of features used to
Figure 3. Synergistic dysregulation versus network size for candidate sub-networks associated with proteomic seeds obtained
from Nibbe et al. Sub-network dysregulation (i.e. mutual information of sub-network mRNA expression profile with phenotype class) versus
network size for candidate sub-networks. All interactors (green squares) and crosstalkers (red diamonds) were scored using (a) GSE10950 and (b)
GSE8671. The blue lines represent the linear interpolation of the means of the estimated null distributions computed for random candidate sub-
networks of size 2,4,8,16,32, and 64, using the respective arrays (see Materials and Methods for details). Vertical bars represent one standard deviation
from the mean.
doi:10.1371/journal.pcbi.1000639.g003
Functional Sub-Networks in Human Colorectal Cancer
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proteomic interactor and CAN (candidate CRC driver genes)
crosstalker sub-networks outperformed the proteomic crosstalkers
(Figure 8a). Performance was similar when the training and
validation sets were reversed, although the performance of
proteomic crosstalkers dropped when more than two sub-networks
were used for classification (Figure 8b). The raw classification data
are provided in Supplemental Table S1.
Discussion
We have shown that proteomic targets showing significant
expression changes for a complex phenotype, such as CRC, provide
valuable inputs for our algorithms designed to discover phenotyp-
ically significant sub-networks with connectivity and proximity to
these targets. In addition, certain crosstalker sub-networks, when
scored with respect to phenotype by the measure of mutual
information, display significant differential synergistic expression at
the level of mRNA with respect to the seed targets. When these
implicated sub-networks contain proteins with no known role in the
disease, they present new opportunities for follow-on mechanistic
experiments to verify the in silico inference of biological significance
in the disease. This point cannot be over-emphasized, because in
our view the promotion of a candidate, disease-associated sub-
network to an functional sub-network with a validated role in
disease must be accomplished by wet lab experiments.
Figure 4. Synergistic dysregulation versus network size for candidate sub-networks associated with proteomic seeds obtained
from Friedman et al. Please see Figure. 3 for annotation.
doi:10.1371/journal.pcbi.1000639.g004
Functional Sub-Networks in Human Colorectal Cancer
PLoS Computational Biology | www.ploscompbiol.org 7 January 2010 | Volume 6 | Issue 1 | e1000639Figure 5. Significant sub-networks induced by proteomic seeds. Network graph visualization of sub-networks induced by Friedman seed,
scored using GSE10950 (a) and Nibbe seed, scored using GSE8671 (b). Proteomic seeds that induced a significant crosstalker sub-network are shown
in red, other proteomic seeds are shown in orange, crosstalkers are black and interactors are white. Visualization was performed with the Pajek
software.
doi:10.1371/journal.pcbi.1000639.g005
Functional Sub-Networks in Human Colorectal Cancer
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proteomic seeds, a number of the same sub-networks showed
significance (.1s from background) when scored by either
GSE10950 or GSE8671. With respect to the driver gene seed,
every sub-network that showed significance when scored by the
GSE8671 array was also found to be significant when scored by
the GSE10950 array. One explanation for why the sub-networks
with respect to a given set of proteomic seeds did not show
complete redundancy between arrays is that the microarrays
represent experiments performed on different pathologic stages of
CRC tumors, very early stage in the case of GSE8671 (adenoma)
versus a more established tumor in GSE10950 (primary). The
pathologic stage of the proteomic samples in the Nibbe seed was
homogenous late stage CRC (Duke’s D) while the Friedman seed
was a mix of mid to late stage samples (Duke’s B–D). This
highlights a potential limitation of an integrated –omics approach,
namely, it is often difficult to establish an optimal match of the
biology underlying the measures made at the level of the proteome
and transcriptome. However, in our case, if the sub-networks
become dysregulated early in the disease and have a role in
maintaining the phenotype through later stages, this limitation can
turn into an opportunity for development of hypotheses regarding
the mechanisms of the progression of CRC. In particular, the
complete overlap of crosstalk sub-networks between arrays
observed with the driver gene seed indicates the synergistic
activity of these sub-networks may be independent of pathologic
stage.
We also noted that only a relatively small fraction of the seeds
induced significant sub-networks, either interactors or crosstalkers,
and this was the case for both the proteomic and the genomic
seeds. One potential explanation for this observation is that
current human PPI networks capture only a very small fraction of
all protein relationships in the human interactome [21], and
therefore cannot be expected to reveal a significant sub-network
for every experimentally determined seed. As these networks
improve, we expect their value in uncovering interesting biology
will only grow.
The classification performance indicates that experimentally-
derived proteomic disease targets combined with our network
search algorithm can discover high-valued sub-networks for
mechanistic in vivo verification. This was consistent with our
hypothesis, and supports the claim that a proteomic seed can
identify sub-networks that provide additional pathways of interest
(e.g CCT2, TCP1). To strengthen this claim, in an independent
cohort of patient biopsies, we validated the differential expression
of several targets in the TCP-1 sub-network, predicted by our
model to be coordinately dysregulated.
The genomic seed showed excellent classification performance,
and crosstalkers were superior in most instances to their
corresponding interactor sub-networks, consistent with our compu-
tational hypotheses. When three or more features were used to train
the classifier they were also better than the proteomic crosstalkers.
However,thisresultisnotentirelyunexpectedastheproteomicdata
has low coverage and may lack key seeds and thus may lack
important sub-networks. However, the favorable classification
performance of the genomic-derived sub-networks may be viewed
as a positive control for this experimental approach. Alternatively, it
is unlikely that all relevant sub-networks are regulated at the level of
transcription, and this may reduce the number of significant sub-
networks discoverable by our approach. Never-the-less, the
approach can be generalized to many proteomics expression data
sets to discover novel sub-networks dysregulated in many complex
diseases.
In many classification applications, high dimensionality is an
important problem and it is often desirable to be able to choose a
small number of features that will provide reasonable perfor-
mance (to overcome ‘‘curse of dimensionality’’). In this respect,
the classification performance provided by only a few sub-
networks is indeed very promising, in that ‘‘crosstalk to proteomic
targets’’ may actually provide a shortcut to the identification of a
compact set of useful sub-network features. As our classification
experiments were carried out in a cross-classification setting, the
high accuracy of classification using up to three sub-networks
indicates that the most significant crosstalker sub-networks were
highly reproducible. Reproducibility is an important concern in
classification applications, since if the sub-network features that
are used are not reproducible across datasets, this will result in
over-fitting. In this regard, the use of proteomic data can also be
considered a tool for obtaining useful biological insights for
feature selection.
Figure 6. Validation of select targets predicted to be dysregulated in TCP1 sub-network. Immunoblot data were obtained from three (540,
534, 507) late-stage matched (N=normal/T=tumor) patient tissue biopsies not used in the original proteomic screen by Nibbe et. al. Values are in
kilodalton (kDa). GSE8671 and GSE10950 represent the ratio of the mean mRNA value (tumor/normal) from the respective microarray array. Fold
change was determined by densitometry.
doi:10.1371/journal.pcbi.1000639.g006
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Proteomic Methods
Target screen. The Nibbe et al. proteomic targets were
determined using two gel-based screens of twelve and six,
respectively, late-stage CRC tumor tissue biopsies (with matched
adjacent normals) obtained from the Case Comprehensive Cancer
Center. Briefly, the biologically significant spots between normal
and tumor were identified by image analysis of the 2D-gels. The
spots were then robotically excised, digested by trypsin, and the
peptide sequences determined by LC-MS/MS. Parent proteins
were subsequently identified by database search. Full experimental
details as well as the lists of the targets identified in both screens
can be found at Nibbe et al [5]. It merits emphasis that the targets
selected for network analysis were highly significant given the
stringent p-values used (,0.01) at the level of peptide and protein
identification. The targets in the Friedman seed were similarly
identified (see the Methods section of Friedman et al.) on a smaller
cohort of paired biopsies (n=6) of mixed stage CRC.
Western blot. The tissue samples were thawed and
homogenized in Lameali buffer with a Polytron mixer. Protein
concentration was determined by a kit (Amersham Biosciences, 2D-
Quant). Aliquots were diluted to 5 ug/ul,and stored at 280uC.
15 ug of total protein was separated by 1D-PAGE on homogeneous
Figure 7. Synergistic dysregulation versus network size for candidate sub-networks associated with the CRC driver gene seeds
obtained from Sjo ¨blom et al. Please see Figure 3 for annotation.
doi:10.1371/journal.pcbi.1000639.g007
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cellulose membrane (40 mA for 4 hours on ice). Membranes were
blocked overnight at 4uC with 5% milk in TBS-T, washed 26with
TBS-T at room temperature, and subsequently incubated with the
primary antibody (Sigma) overnight at 4uC. The membranes were
once again washed 26at room temperature and incubated with the
secondary antibody (Cell Signaling) for two hours. The membranes
were then washed 36 with TBS-T, incubated with ECL reagent
(Pierce) and exposed from one to ten minutes (protein dependent).
Fold change was determined using the 2D-QUANT software
(Amersham Bioscience).
Computational Methods
The computational framework for integrating proteomic,
transcriptomic, and interactomic data to discover sub-networks
implicated in complex phenotypes is shown in Figure 1. As seen
in the figure, we first identify disease targets with significant
differential expression with respect to control, via proteomic
screening as described above. Once these targets, called proteomic
seeds, are identified, we map these seeds on the PPI network
obtained from HPRD to identify proteins that are functionally
associated with the proteomic seeds.
In order to develop biologically sound measures to quantify the
functional association between proteins, we develop information
flow based algorithms to compute crosstalk scores, which capture
network proximity and connectivity to proteomic seeds. We
discuss this procedure in Subsections A and B. In order to account
for experimental artifacts, incompleteness of data, and ascertain-
ment bias, we use Monte Carlo simulations to assess the
significance of the crosstalk scores computed by these algorithms.
Our statistical evaluation scheme is based on a reference model
that captures the basic characteristics of the proteomic seeds, in
terms of the number of seeds and their degree distribution. This
procedure is described in Subsection C.
Subsequently, for each proteomic seed, we construct two
‘‘candidate sub-networks’’: (i) sub-network induced by all inter-
acting partners of the seed protein, (ii) sub-network induced by the
interacting partners that have significant crosstalk scores (in our
experiments, we use a p-value cut-off of 0.001 to determine
‘‘significant crosstalkers’’). Finally, we evaluate the mutual
information score of each candidate sub-network with respect to
the phenotype of interest (in this paper, CRC), using mRNA
expression data for test and control samples. For this purpose, we
use an established information-theoretic scheme that quantifies
synergistic differential expression in terms of the mutual
information between the aggregate expression of the sub-network
and disease classes across samples. This procedure is explained in
Subsection D. In order to assess the statistical significance of
synergistic differential expression, we also use Monte Carlo
simulations based on reference models that accurately capture
the basic topological characteristics of each sub-network. This
procedure is explained in Subsection E. We then use identified
sub-networks to develop classifiers for predicting disease class in
CRC. This procedure is explained in Subsection F.
Figure 8. Cross-validation performance comparison of sub-network based classifiers. The sub-networks induced by proteomic and
genomic seeds were first ranked by mutual information with phenotype (MI). Then the normalized mRNA expression values for the genes were
aggregated to compute a feature for each sub-network with significant MI. These features were used to train an SVM-based classifier to distinguish
normal from tumor using GSE10950, and then cross-validated on GSE8671 (a), and vice-versa (b).
doi:10.1371/journal.pcbi.1000639.g008
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Association, and Network Topology
Systematic studies of differentially expressed genes in certain
phenotype classes show that these genes are related to each other
in molecular networks, composed of protein-protein interactions,
transcriptional regulatory interactions, and metabolic interactions
[22]. In one of the early algorithmic studies, Ideker et al. [23]
develop a method for identifying differentially expressed metabolic
sub-networks with respect to GAL80 deletion in yeast. This
method is based on searching for connected groups of enzymes
within the yeast metabolic network, such that the aggregate
differential expression of genes coding these enzymes is statistically
significant. Variations of this method prove useful in identifying
multiple gene markers implicated in a variety of diseases, including
prostate cancer [24], melanoma [25], and diabetes [26]. Building
on these results, information theoretic schemes for assessing
synergistic differential expression are also shown to be effective in
network based disease classification [11,27].
While differential network analysis is effective in identifying
multiple gene markers, most of the existing methods utilize
network information to primarily find the genes that are
connected, hence potentially related to each other. In other
words, these approaches do not take into account network
topology, connectivity patterns, or degree of connectivity between
proteins. This is because (i) much of the available network
information is noisy and incomplete [28], therefore, connectivity
patterns cannot be interpreted as well-defined wiring schemes, and
(ii) network models (particularly, high-throughput protein-protein
interactions) provide only a high-level qualitative description of the
information flow in the cell. However, several studies show that
variations in molecular expression can be interpreted in terms
of network topology (e.g, subunits of a protein complex are co-
expressed significantly over a time course [29], functional
similarity of proteins correlates with proximity in a network of
interactions [30,31].
Motivated by these considerations, we develop network-based
scoring schemes to quantify the crosstalk between proteomic seeds
and the rest of the proteins in a network of interactions. Based on
the premise that synergistic changes in transcriptional expression
may be associated with significant changes in proteomic activity,
we expect that proteins that demonstrate significant crosstalk with
proteomic seeds will be good candidates for being implicated in
the phenotype of interest. In order to assess the crosstalk between a
group of proteomic targets and any other protein in the network
accurately, we develop information flow based algorithms, as
discussed in the next section.
Network Crosstalk: Capturing Functional Association via
Connectivity and Proximity
Let G=(V,E) be a network of protein interactions, where V
consists of the proteins in the network, and an undirected edge
uvME represents an interaction between proteins uMV and vMV. For
convenience, we also define N(v) as the set of interacting partners
of protein vMV, i.e., N(v)={uMV: uvME}. Let S#V be the set of
proteomic seeds, i.e., the proteins that are identified by proteomic
studies to exhibit significant fold change with respect to the
phenotype of interest. Our objective is to compute a score a(v) for
each protein vMV, to quantify the network crosstalk between v and
the proteins in S. Here, network crosstalk is used as an indicator of
functional association between proteins.
In order to develop a biologically sound measure of network
crosstalk, we rely on the following observations: (i) Functional
similarity between two proteins, as measured by semantic
similarity of Gene Ontology annotations [32], is significantly
correlated with their network proximity, as measured by the
shortest path (number of hops) between these proteins [30,31]. (ii)
Existence of multiple alternate paths between two proteins is an
indicator of their functional association, since functional multiple
paths are often conserved through evolution owing to their
contribution to robustness against perturbations, as well as
amplification of signals [33].
To incorporate both the number of hops and multiple alternate
paths into the assessment of crosstalk between proteins, we use an
information flow based algorithm based on random walks with
restarts [34]. This algorithm can be considered a generalization of
Google’s well-known page-rank algorithm [35]. Furthermore, a
special case of the proposed crosstalk score, when |S|=1, is a
network proximity measure [34] known to be closely related to
commute distance and effective resistance [36] in graphs. Similar
graph-theoretic measures are also used to identify functional
modules in PPI networks [37], annotation of protein function [38],
and prioritization of disease genes [15–17].
We assign crosstalk scores to all proteins in the network for a
given S by simulating a random walk as follows. The random walk
starts at a randomly chosen protein in S. At each step, when the
random walk is at some protein v, it either moves to an interacting
partner of v with probability 12r, or it restarts at a protein in S
with probability r. Here, the parameter 0#r#1 is called the restart
probability (in our experiments, we use r=0.5). For each move,
the interacting partner to be moved to is selected uniformly at
random from N(v). However, the move probabilities can also be
adjusted to reflect the confidence of each interaction, so that more
reliable interactions contribute more to the quantification of
crosstalk. In other words, one can define the probability of a move
from v to u as P(u,v)=w(u,v)/Su9MN(v) w(u9,v)i fuMN(v), 0 otherwise.
Here, w(u,v) denotes the reliability of the interaction between u and
v. Similarly, for each restart, the protein to be restarted is selected
uniformly at random from S. These probabilities can also be
adjusted to reflect the significance of the fold change of each
protein in S, so that proteins with more significant fold change are
considered as more reliable seed proteins. In other words, one can
define the probability of restart at uMV as r(u)=zP(u)/Su9MS zP(u9)i f
uMS and 0 otherwise. Here, zP(u) denotes the z-score of the fold
change of u with respect to the phenotype of interest, based on
proteomic screening.
Based on this random walk model, we define the crosstalk
between the proteins in S and each protein vMV as the relative
amount of time spent at v by such an infinite random walk, or
equivalently, the probability that the random walk will be at
protein v at a randomly chosen time step after the random walk
proceeds for a sufficiently long time. More precisely, let at denote a
|V|-dimensional vector, such that at(v) is equal to the probability
that the random walk will be at protein v at step t, where IatI1=1
(here, I.I1 denotes the 1-norm of a vector, defined as the sum of
magnitudes of its elements). Let P denote the stochastic matrix
derived from network G=(V,E), i.e., P(u,v)=1/|N(v)| if uvME,0
otherwise. Then, we have
atz1~ 1{r ðÞ Patzrr: ð1Þ
where r denotes the restart vector with r(u)=1/|S| for uMS, and 0
otherwise. Then, letting a0=r, the vector containing the crosstalk
scores for each node in the network is given by a=limtR‘ at.
Observe that this formulation lends itself to an iterative algorithm
to compute crosstalk scores efficiently, where each iteration
requires O(|E|) time, since P is a sparse matrix with 2|E| non-
zero entries.
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corresponds to its largest eigenvalue (with numerical value 1), i.e.,
a(v) is exactly equal to the page rank of v in G for all vMV.
Therefore, the crosstalk score of a protein is not only an indicator
of its connectivity and proximity to seed proteins, but it is also
influenced by the centrality of the protein in the network. In order
to account for such sources of bias, as well as the choice of
parameter r (in our experiments, we use r=0.5), we adjust the
crosstalk scores statistically as we discuss in the next section.
Dealing with Experimental Artifacts, Ascertainment Bias,
and Incomplete Data
Due to variability in physical properties of proteins and other
experimental artifacts, it is likely that there will be significant
ascertainment bias in the selection of proteomic seeds, as well as
the availability of interaction data for each protein [39]. Indeed,
our results show that the seed proteins extracted by proteomic
screening are likely to be highly connected in the PPI network
derived from HPRD. More specifically, the 60 proteins that are
identified to have significant fold change (p,0.01) in late stages of
human colorectal cancer have 24.1 interactions in HPRD on an
average, while the average degree of a protein in the HPRD
network is 9.1. Consequently, highly connected proteins in the
network are likely to be assigned artificially high crosstalk scores
just by chance. Since available network data is often incomplete
and prone to ascertainment bias, these effects are likely to amplify
the ascertainment bias and skew the results toward well-studied
proteins. However, we are very interested in finding those proteins
that are relatively less characterized but may provide novel insights
into phenotype. Therefore, the crosstalk scores described above
need to be assigned significance scores based on reliable statistical
models.
In order to deal with such experimental and data-related
sources of bias, we use a reference model that captures the degree
distribution of seed proteins accurately. Namely, for a given seed
set S, we generate a random instance S
(i) representative of S as
follows. For every protein uMS, we create a bucket B(u) of proteins
in the network, such that <uMS B(u)=V and B(u)>B(u9)=Ø for all
u, u
9MS. Here, protein vMV is assigned to bucket B(u)i f
|N(v)2N(u)|#|N(v)2N(u9)| for all u9MS and ties are broken
randomly. Then, we construct S
(i) by choosing one protein from
each bucket uniformly at random, so that |S
(i)|=|S|. Observe
that each bucket consists of proteins that have similar number of
interactions with a particular seed protein; therefore, each seed
protein is represented in S
(i) by exactly one protein in terms of its
number of interactions. Consequently, the expected total degree of
the proteins in S
(i) is likely to be very close to the total degree of the
proteins in S. Once a random instance S
(i) is generated, we
compute the corresponding crosstalk vector a
(i) by letting
r
(i)(u)=1/|S
(i)| for uMS
(i), and 0 otherwise.
Repeating this procedure n times, where n is sufficiently large (we
use n=1000 in our experiments), we obtain a sampling {a
(1), a
(2),
…, a
(n)} of the null distribution of crosstalk scores, with respect to
seed sets that are representative of S in terms of their size and degree
distribution. We then estimate the mean mS=S1#i#na
(i)/n and
standard deviation sS
2=S1#i#n(a
(i)2mS)
2/(n21) of the null
distribution of crosstalk scores for S using this sample. Subsequently,
we compute adjusted crosstalk scores
zs(v)~(a(v){ms(v))=as(v) ð2Þ
for each protein vMV. These adjusted crosstalk scores represent the
statistical significance of the crosstalk between each protein and the
proteins in the seed set, accounting for the centrality of the protein
the network, as well as the degree distribution of seed proteins.
Assessing Synergistic Dysregulation of Candidate Sub-
Networks
Once all proteins in the network are scored according to their
crosstalk with proteomic seeds, we construct candidate sub-
networks as follows:
1. Interactor sub-networks: For each proteomic seed u, the
sub-network induced by its interacting partners in the network
(N(u)) is considered a candidate sub-network, based on the
hypothesis that significant changes in the expression of a
protein may be associated with synergistic changes in the
transcriptional expression of proteins in its neighborhood.
2. Crosstalker sub-networks: For each proteomic seed u, the
sub-network induced by the proteins in N(u) that have
significant adjusted crosstalk scores with respect to S is
considered a candidate sub-network, based on the hypothesis
that sub-networks composed of proteins with significant
crosstalk to the proteomic seeds (as opposed to solely
interacting with one proteomic seed) are likely to exhibit
significant synergistic differential expression.
Formally, the set of candidate sub-networks is defined as
C(S)={N(u):uMS}<{N
*(u):uMS}, where N
*(u)={vMN(u): zS(v).z
*}.
Here, z
* denotes the cut-off for adjusted crosstalk scores to be
considered significant. In our experiments, we use z
*=3.45, to
reflect a p-value cut-off of 0.001, under the assumption of normally
distributed crosstalk scores.
For each candidate sub-network Q in C(S), we quantify the
synergistic expression of the proteins in Q using an information-
theoretic scheme developed by Chuang et al. [11]. Namely, for
protein vMV, let e(v) denote the properly normalized m-dimensional
mRNA expression vector, provided by genome-scale transcrip-
tomic screening of m disease and control samples. Let c denote an
m-dimensional binary vector indicating the phenotype class of each
sample, such that c(i)=1 if the ith sample is diagnosed with the
disease, 0 otherwise. Furthermore, define the aggregate expression
vector e(Q) for the sub-network induced by set of proteins Q as
e(Q)~
X
v[Q
e(v)=
ﬃﬃﬃﬃﬃﬃﬃ
jQj
p
: ð3Þ
Then, the synergistic differential expression Q(Q) of the genes
coding for proteins in Q with respect to the phenotype of interest is
given by the mutual information between e(Q) and c, i.e.,
(Q)~I e(Q),c ðÞ ~H e(Q) ðÞ zH(c){H e(Q),c ðÞ ð 4Þ
Here, e(Q) denotes a discrete-valued vector obtained by quantizing
e(Q) into k bins, H(x) denotes the entropy of a discrete-valued
vector x over a finite alphabet A, i.e., H(x)=SaMA2p(a)log(p(a)), and
p(a)=|{i:x(i)=a}|/m (in the context of our problem, A represents
the set of bins). In this paper, we use k=6, since this value of k was
found to provide reasonable estimates for mutual information in
our experiments.
Statistical Significance of Synergistic Dysregulation
Finally, we assess the statistical significance of synergistic
differential expression for each candidate sub-network. In order
to do so, for a given QMC(S), we generate a null distribution for
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topological properties of Q. Since Q is composed of proteins that
are connected to each other via a single protein (that is, the
corresponding proteomic seed), the null distribution should also be
derived from sub-networks that consist of the same number of
proteins in Q, which are connected to each other through a single
protein in the network. Therefore, we first construct a bag D
of proteins in the network with degree at least |Q|, i.e,
D={vMV:|N(v)|$|Q|}. Subsequently, we choose a protein v from
D uniformly at random. Finally, we choose |Q| proteins uniformly
at random from N(v) to construct a random instance Q
(i)
representative of Q. Repeating this procedure n times (in our
experiments, we use n=1000) and computing Q(Q
(i)), we obtain a
null distribution of synergistic differential expression for sub-
networks similar to Q. Observe that, only the size of Q
(i) depends
on Q in this procedure. For this reason, in our experiments, we do
not explicitly generate a null distribution for each QMC(S). Rather,
we generate a null distribution for sub-networks of size 2, 4, 8, 16,
32, 64. Then we interpolate the mean and standard deviation of
synergistic differential expression for these distributions, to obtain
a curve that characterizes the behavior of synergistic differential
expression with respect to sub-network size.
Sub-Network Classification
In order to assess the reproducibility of discovered subnetworks
across different data sets and evaluate the potential of the proposed
framework for feature selection in classification of CRC, we
perform cross-classification experiments. In these experiments, we
use the aggregate expression profiles (e(Q)) of crosstalker and
interactor subnetworks associated with Nibbe and CAN seeds as
features for classification. For this purpose, in each experiment, we
select the crosstalker (or interactor) subnetworks with synergistic
differential expression (Q(Q)) one standard deviation above random
mean, according to a specific mRNA expression data set (e.g.,
GSE8671). Assume that there are K such subnetworks. Then, for
each k#K, we use the k subnetworks with maximum Q(Q) to train
an SVM classifier on the same data set (GSE8671), using Matlab’s
svmtrain function. Subsequently, we use this classifier to predict
the class (tumor vs. normal) of each sample on a different data set
(e.g., GSE10950), using Matlab’s svmclassify function. We
evaluate the performance of the classifier using the harmonic
mean of precision (selectivity) and recall (sensitivity), known as the
F-measure, defined as
F~
2|precision|recall
precisionzrecall
:
Here, precision is the fraction of true positives among all samples
classified as tumor and recall is the fraction of tumor samples called
accurately by the classifier among all tumor samples.
Supporting Information
Table S1 Sub-network mutual information and classification
scores. Cross-classification data are listed for all significant
(MI.=0.35) sub-networks induced by the respective seed.
‘‘CAN’’ refers CRC-driver gene seeds.
Found at: doi:10.1371/journal.pcbi.1000639.s001 (0.14 MB
DOC)
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